These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32345708)

  • 41. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.
    Yeung K; Basu A; Hansen RN; Watkins JB; Sullivan SD
    Med Care; 2017 Feb; 55(2):191-198. PubMed ID: 27579915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.
    Conti RM; Nikpay SS; Buntin MB
    JAMA Netw Open; 2019 Oct; 2(10):e1914141. PubMed ID: 31664442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the Valley of Savings: Minimizing Part D Costs and Optimizing Drug Therapy Outcomes in Medicare Beneficiaries With Developmental Disability.
    Rogan EL; Ranson CA; Mori TK; Park SK; Lam HM; Legaspi JF; Tran LK; Cameros CJM; Blackburn AN; Lee ST; Valle-Oseguera CS; Pham CN; Woelfel JA; Patel RA
    Intellect Dev Disabil; 2019 Jun; 57(3):234-241. PubMed ID: 31120407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth in prescription drug spending among insured elders.
    Thomas CP; Ritter G; Wallack SS
    Health Aff (Millwood); 2001; 20(5):265-77. PubMed ID: 11558712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Do interventions that address patient cost-sharing improve adherence to prescription drugs? A systematic review of recently published studies.
    Sensharma A; Yabroff KR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):263-277. PubMed ID: 30628493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada.
    Marshall DA; Willison DJ; Grootendorst P; LeLorier J; Maclure M; Kulin NA; Sheehy OE; Warren L; Sykora K; Rahme E
    Health Policy; 2007 Nov; 84(1):1-13. PubMed ID: 17570558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Federal and Individual Spending on the 10 Costliest Medications in Medicare Part D from 2011 to 2015.
    Watanabe JH; Chau DL; Hirsch JD
    J Am Geriatr Soc; 2018 Aug; 66(8):1621-1624. PubMed ID: 29972589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Difference in drug cost between private and public drug plans in Quebec, Canada.
    M C; A F; I C; M S; L B
    BMC Health Serv Res; 2022 Feb; 22(1):200. PubMed ID: 35164750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013.
    Brouwer ED; Basu A; Yeung K
    Pharmacoeconomics; 2019 Oct; 37(10):1287-1300. PubMed ID: 31270747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association Between Care Management and Outcomes Among Patients With Complex Needs in Medicare Accountable Care Organizations.
    Ouayogodé MH; Mainor AJ; Meara E; Bynum JPW; Colla CH
    JAMA Netw Open; 2019 Jul; 2(7):e196939. PubMed ID: 31298714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-Cost Users of Prescription Drugs: A Population-Based Analysis from British Columbia, Canada.
    Weymann D; Smolina K; Gladstone EJ; Morgan SG
    Health Serv Res; 2017 Apr; 52(2):697-719. PubMed ID: 27087391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
    Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
    Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of a cost-sharing drug insurance plan on drug utilization among older people.
    Blais L; Boucher JM; Couture J; Rahme E; LeLorier J
    J Am Geriatr Soc; 2001 Apr; 49(4):410-4. PubMed ID: 11347784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.
    Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP
    JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
    Buttorff C; Andersen MS; Riggs KR; Alexander GC
    Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prescribing Patterns and Costs Associated with Postoperative Eye Drop Use in Medicare Beneficiaries Undergoing Cataract Surgery.
    Zafar S; Wang P; Schein OD; Srikumaran D; Makary M; Woreta FA
    Ophthalmology; 2020 May; 127(5):573-581. PubMed ID: 31952884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.